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The advent of a new reverse genetics system for reoviruses, described in this issue of Cell Host &
Microbe by Kobayashi et al., opens new horizons of investigation into the molecular mechanisms
governing dsRNA virus replication and pathogenesis. The elegant approach for recombinant reovirus
recovery from a set of plasmid DNAs provides a template for designing similar reverse genetics
systems for other dsRNA viruses associated with considerable morbidity and mortality in humans.In recognition of the power of introduc-
ing specific changes in a given viral
genome, reverse genetic strategies
were vigorously pursued for many
positive- and negative-stranded RNA
viruses and signified a monumental
achievement that created numerous
opportunities for applied and basic re-
search. Reverse genetics techniques
provided the tools for resurrecting the
1918 influenza virus and other rare
viruses from sequence fragments
(Tumpey et al., 2005), for engineering
recombinant virus vaccines, for devel-
oping heterologous viral expression
vectors for vaccine and gene therapy,
and for exploring the structure and
function of viral genes in replication
and pathogenesis (Deming et al.,
2006; Horimoto and Kawaoka, 2006).
However, achieving a molecularly
cloned reovirus proved elusive, a
technological gap that limited the po-
tential of dsRNA virus research.
The Reoviridae, specifically reovi-
ruses, have provided fundamental
advances in virus-host interactions and
pathogenesis. The segmented RNA
genomes are elegantly organized for
genetic reassortment studies that
mapped phenotypes with specific viral
genes, as well as demonstrating that
reversion mutations can occur extra-
genetically (Ramig et al., 1977). The
power of genetic reassortment, so-
called forward genetics, propelled
reovirus pathogenesis research to the
virus research forefront by defining
the genetic basis of complex patho-
genic traits. Reovirus research laid
the framework for dissecting the differ-
ences between neural or hematoge-
nous spread (Tyler et al., 1986), as90 Cell Host & Microbe 1, April 2007 ª20well as the interaction of specific viral
genes with variant host signaling
pathways and cell death. More recent
studies have used reoviruses as ex-
perimental cancer therapies. Of note,
the complexity of the reovirus docking
and entry steps, which involve a series
of primary host receptors and stabiliz-
ing partners that trigger a cascade of
protein processing and conformational
changes during penetration, and tran-
scription serves as a paradigm model
for nonenveloped virus entry and
RNA synthesis (Agosto et al., 2006;
Barton et al., 2001; Guglielmi et al.,
2006; Tao et al., 2002).
In this issue of Cell Host & Microbe,
Kobayashi et al. expand upon these
historic achievements by describing
the first complete plasmid-based re-
verse genetic approach that allows for
the rescue of a recombinant double-
stranded RNA virus. Each reovirus
segment was precisely engineered
using positional cloning downstream
of a T7 RNA polymerase promoter,
designed to ensure that each of the
ten transcribed segments of plus-
stranded RNA terminates with a 50
guanosine. Following transfection of
the ten plasmid DNAs, nascent tran-
scripts were expressed containing
a hepatitis delta virus ribozyme fused
to the 30 terminus following coinfection
with anattenuatedT7RNApolymerase-
expressing vaccinia virus. Following
expression, ribozyme activity gener-
ated an authentic 30 end of each
genome segment. Although infectious
centers were low following transfec-
tion of the plasmid DNAs, recombinant
viruses were routinely isolated and
encode the appropriate marker muta-07 Elsevier Inc.tions engineered into the genome
fragments (Kobayashi et al., 2007).
Interestingly, the success of plasmid-
initiated reovirus infection was not
limited by the amount of template or
transfection efficiency, or the pres-
ence of high-level expression of the
replication proteins m2, mNS, and
sNS, which form viral inclusions in in-
fected cells. Thus, it seems likely that
further improvements in the system
are possible, perhaps encoded in
other viral or cellular factors. In addi-
tion, the authors genetically confirm
that a specific mutation in the attach-
ment protein s1 alters cleavage sus-
ceptibility and controls growth in the
murine intestine and systemic spread
to the CNS. Even more remarkable,
reovirus was engineered to express
green fluorescent protein fused with
a portion of the s3 open reading frame
and successfully propagated by trans-
complementation in L cells stably
expressing wild-type s3. In cells lack-
ing the essential s3 gene product, re-
combinant viruses were replication
deficient (Kobayashi et al., 2007).
These studies elegantly provide a
framework for the development of
similar reverse genetic systems for
other important reovirus pathogens of
human and animals.
It is not possible to overstate the
importance of the development of
a dsRNA reverse genetics strategy.
Reovirus infection is usually a mild
self-limiting disease in humans, mak-
ing reoviruses excellent heterologous
vaccine vectors for expressing foreign
genes and eliciting mucosal immunity
in the gastrointestinal tract. A broad
host range allows for their use as
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Previewshuman and animal vaccine vectors.
The reovirus paradigm contains nu-
merous unifying features in structure
and replication with other highly
pathogenic Reoviridae, including the
strains that cause a considerable bur-
den on human health globally. It is
likely that the insights presented here
will quickly be extrapolated to other
Reoviridae familymembers, like rotavi-
ruses, leading to new therapies for the
improvement of world health. Rotavi-
rus infections cause 500,000 deaths
per year globally in young children
and infants, mostly in the developing
world. Although two new live virus vac-
cines have recently been licensed, an
earlier vaccine, Rota Shield, was with-
drawn in 1999 after postmarketing sur-
veillance identified an association with
intussusception (Glass et al., 2005).
How efficacious will these new live
rotavirus vaccines prove in infants
and children of the developing world?
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Immunity refers to all biological func-
tions conferring protection to an indi-
vidual against the disruptive properties
of various entities, includingmolecules,
cells, organs, and organisms. Study of
the immune system has been divided
into innate and adaptive immunity. In-
nate immunity refers to the intrinsic
ability of an organism to detect and
counteract the potentially harmful
activities of nonself (Janeway and
Medzhitov, 2002). The concept of
adaptive immunity emerged from the
observation that, once primed witha strong approach to identify and de-
code the function of virulence alleles
in pathogenesis. Rational design of re-
combinant live rotavirus vaccines con-
taining defects in virulence alleles will
provide an approach to improve safety
and efficacy. In an era focusing on
translation research and the impact
of the biotechnology revolution on the
global economy, the history of reovi-
ruses reaffirms the critical importance
of basic science and model organisms
as catalysts for key breakthroughs in
the scientific process.
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recognized in both vertebrates and
invertebrates (Hoffmann et al., 1999).
However, the processes underlying
adaptive immunity have only been
documented in vertebrates and are
therefore considered to be an evolu-
tionarily acquired trait added to the
pre-existing innate immune system.
In a recent report published in PLoS
Pathogens, D. Schneider and col-
leagues challenge this view, providing
data to support the idea that inverte-
brate immunity can indeed adapt
(Pham et al., 2007).
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